Literature DB >> 18077550

CMP substitutions preferentially inhibit polysialic acid synthesis.

Tatsuo Miyazaki1, Kiyohiko Angata, Peter H Seeberger, Ole Hindsgaul, Minoru Fukuda.   

Abstract

It is widely reported that derivatives of sugar moieties can be used to metabolically label cell surface carbohydrates or inhibit a particular glycosylation. However, few studies address the effect of substitution of the cytidylmonophosphate (CMP) portion on sialyltransferase activities. Here we first synthesized 2'-O-methyl CMP and 5-methyl CMP and then asked if these CMP derivatives are recognized by alpha2,3-sialyltransferases (ST3Gal-III and ST3Gal-IV), alpha2,6-sialyltransferase (ST6Gal-I), and alpha2,8-sialyltransferase (ST8Sia-II, ST8Sia-III, and ST8Sia-IV). We found that ST3Gal-III and ST3Gal-IV but not ST6Gal-I was inhibited by 2'-O-methyl CMP as potently as by CMP, while ST3Gal-III, ST3Gal-IV, and ST6Gal-I were moderately inhibited by 5-methyl CMP. Previously, it was reported that polysialyltransferase ST8Sia-II but not ST8Sia-IV was inhibited by CMP N-butylneuraminic acid. We found that ST8Sia-IV as well as ST8Sia-II and ST8Sia-III are inhibited by 2'-O-methyl CMP as robustly as by CMP and moderately by 5-methyl CMP. Moreover, the addition of CMP, 2'-O-methyl CMP, and 5-methyl CMP to the culture medium resulted in the decrease of polysialic acid expression on the cell surface and NCAM of Chinese hamster ovary cells. These results suggest that 2'-O-methyl CMP and 5-methyl CMP can be used to preferentially inhibit sialyltransferases, in particular, polysialyltransferases in vitro and in vivo. Such inhibition may be useful to determine the function of a carbohydrate synthesized by a specific sialyltransferase such as polysialyltransferase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077550      PMCID: PMC2782372          DOI: 10.1093/glycob/cwm132

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  37 in total

1.  Macrothrombocytopenia with abnormal demarcation membranes in megakaryocytes and neutropenia with a complete lack of sialyl-Lewis-X antigen in leukocytes--a new syndrome?

Authors:  T B Willig; J Breton-Gorius; C Elbim; V Mignotte; C Kaplan; R Mollicone; C Pasquier; A Filipe; F Miélot; J P Cartron; M A Gougerot-Pocidalo; N Debili; J Guichard; J P Dommergues; N Mohandas; G Tchernia
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

2.  Unique disulfide bond structures found in ST8Sia IV polysialyltransferase are required for its activity.

Authors:  K Angata; T Y Yen; A El-Battari; B A Macher; M Fukuda
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

3.  Primary structure of beta-galactoside alpha 2,6-sialyltransferase. Conversion of membrane-bound enzyme to soluble forms by cleavage of the NH2-terminal signal anchor.

Authors:  J Weinstein; E U Lee; K McEntee; P H Lai; J C Paulson
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

4.  A small-molecule modulator of poly-alpha 2,8-sialic acid expression on cultured neurons and tumor cells.

Authors:  L K Mahal; N W Charter; K Angata; M Fukuda; D E Koshland; C R Bertozzi
Journal:  Science       Date:  2001-10-12       Impact factor: 47.728

Review 5.  Chemistry, metabolism, and biological functions of sialic acids.

Authors:  R Schauer
Journal:  Adv Carbohydr Chem Biochem       Date:  1982       Impact factor: 12.200

6.  Molecular defects that cause loss of polysialic acid in the complementation group 2A10.

Authors:  M Windfuhr; A Manegold; M Muhlenhoff; M Eckhardt; R Gerardy-Schahn
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

7.  Differential biosynthesis of polysialic acid on neural cell adhesion molecule (NCAM) and oligosaccharide acceptors by three distinct alpha 2,8-sialyltransferases, ST8Sia IV (PST), ST8Sia II (STX), and ST8Sia III.

Authors:  K Angata; M Suzuki; J McAuliffe; Y Ding; O Hindsgaul; M Fukuda
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

8.  Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA.

Authors:  H Sasaki; B Bothner; A Dell; M Fukuda
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

9.  Chemical remodelling of cell surfaces in living animals.

Authors:  Jennifer A Prescher; Danielle H Dube; Carolyn R Bertozzi
Journal:  Nature       Date:  2004-08-19       Impact factor: 49.962

10.  Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid:nucleoside conjugate having sialyltransferase inhibiting activity.

Authors:  I Kijima-Suda; Y Miyamoto; S Toyoshima; M Itoh; T Osawa
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

View more
  5 in total

1.  The Polybasic Region of the Polysialyltransferase ST8Sia-IV Binds Directly to the Neural Cell Adhesion Molecule, NCAM.

Authors:  Gaurang P Bhide; Gerd Prehna; Benjamin E Ramirez; Karen J Colley
Journal:  Biochemistry       Date:  2017-03-03       Impact factor: 3.162

Review 2.  Metabolic glycoengineering: sialic acid and beyond.

Authors:  Jian Du; M Adam Meledeo; Zhiyun Wang; Hargun S Khanna; Venkata D P Paruchuri; Kevin J Yarema
Journal:  Glycobiology       Date:  2009-08-12       Impact factor: 4.313

3.  Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migration.

Authors:  Yousef M J Al-Saraireh; Mark Sutherland; Bradley R Springett; Friedrich Freiberger; Goreti Ribeiro Morais; Paul M Loadman; Rachel J Errington; Paul J Smith; Minoru Fukuda; Rita Gerardy-Schahn; Laurence H Patterson; Steven D Shnyder; Robert A Falconer
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

Review 4.  Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?

Authors:  Silvia Pietrobono; Barbara Stecca
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

5.  Withania somnifera water extract as a potential candidate for differentiation based therapy of human neuroblastomas.

Authors:  Hardeep Kataria; Renu Wadhwa; Sunil C Kaul; Gurcharan Kaur
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.